Spotify Apple Youtube

Category: NASH

All Podcast Categories
S4-31.1 - Mazen Noureddin on "NASH Monopoly"

S4-31.1 – Mazen Noureddin on “NASH Monopoly”

Roger Green is joined by KOL Mazen Noureddin to discuss a complex and developing NASH therapeutic landscape and takeaways from an exciting month of meetings. This is the first conversation of a series of deep-dive episodes dedicated to unpacking the 2023 EASL Congress and the 83rd annual American Diabetes Association Scientific Sessions.

July 9, 2023
S4-30.4 - EASL Congress 2023: Final Takeaways

S4-30.4 – EASL Congress 2023: Final Takeaways

Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this final conversation the panelists revisit some of the more interesting moments of the meeting before answering a question around what takeaways will reshape the way we think and act moving forward.

July 7, 2023
S4-30.3 - EASL Congress 2023: More Posters and Presentations

S4-30.3 – EASL Congress 2023: More Posters and Presentations

Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this conversation each panelist revisits the posters and presentations they found compelling. As expected from such a diverse group, the discussion touches on a range of fascinating topics all worth consideration.

July 7, 2023
S4-30.1 - EASL Congress 2023: Nomenclature Rollout

S4-30.1 – EASL Congress 2023: Nomenclature Rollout

Hannes Hagström, Michelle Long, Rachel Zayas, Jeff McIntyre, Michael Betel and Roger Green get together for an in-depth wrap-up session on EASL Congress 2023. In this first of four conversations, the panelists share their initial impressions before diving into the implications of the new nomenclature rollout.

July 7, 2023
S4-29.3 - EASL Congress 2023: Final Thoughts on Days 1-3

S4-29.3 – EASL Congress 2023: Final Thoughts on Days 1-3

Surfing NASH conducted on-site coverage from EASL Congress 2023 in Vienna with Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green. This final conversation around days 1-3 explores the landscape of AI in the context of better understanding liver diseases. The group also discusses FGF-21 agents, NAIL-NIT data and more.

July 7, 2023
S4-29.2 - EASL Congress 2023: Challenges in Patient Screening and the “2nd Wave” of NASH Therapeutics

S4-29.2 – EASL Congress 2023: Challenges in Patient Screening and the “2nd Wave” of NASH Therapeutics

Surfing NASH conducted on-site coverage from EASL Congress 2023 in Vienna with Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green. In this conversation the group discusses a session that Jörn co-chaired on challenges in screening patients for fatty liver diseases. Notes touch on how time restrictions obstruct frontline treaters from offering both adequate screening and support lifestyle interventions simultaneously. The group goes on to consider the potential of dual agonists efinopegdutide and pemvidutide.

July 7, 2023
S4-E29.1 - EASL Congress 2023: Presentation on MAESTRO-NASH Phase 3 Results

S4-E29.1 – EASL Congress 2023: Presentation on MAESTRO-NASH Phase 3 Results

Surfing NASH conducted on-site coverage from EASL Congress 2023 in Vienna with Ian Rowe, Michael Betel, Jörn Schattenberg and Roger Green. In this conversation the group shares their initial impressions of the first three days of the meeting. Notably, they explore Stephen Harrison’s presentation of the highly anticipated MAESTRO-NASH Phase 3 results.

July 7, 2023
Stay In Touch
Apple Spotify Youtube

Sponsoring Partnerships

Sponsoring partnerships with SurfingMASH present a multifaceted avenue for companies seeking to amplify their brand presence and engage with targeted audiences.

Learn More